Grants per year
- 75 - 100 out of 1,103 results
Search results
-
Prot #UWSC10294/NU UWF17D02: A Multicenter, Randomized, Double‐Blinded, Placebo‐Controlled, Phase 3 Trial of Adjuvant Avelumab (Anti‐PDL‐1 Antibody) in Merkel Cell Carcinoma Patients with Clinically Detected Lymph Node Metastases
University of Washington, EMD Serono Research & Development Institute, Inc.
4/1/18 → 5/31/22
Project: Research project
-
Harnessing Druggable Synthetic Lethal Interactions in Triple-Negative Breast Cancer with Elevated MYC Expression
Horiuchi, D., Mendillo, M. L., Santa-Maria, C. A. & Vasilopoulos, A.
U.S. Army Medical Research and Materiel Command
4/1/18 → 3/31/22
Project: Research project
-
-
Characterization of Chromatin Nanoarchitecture of Ovarian Cancer Stem Cells
Ovarian Cancer Research Fund Alliance
3/1/18 → 2/28/19
Project: Research project
-
Prot #CPDR001XUS01: Modular Phase 2 Study to Link Combination Immune-Therapy to Patients with Advanced Solid and Hematologic Malignancies Module 9: PDR001 Plus LAG525 for Patients with Advanced Solid and Hematologic Malignancies
United BioSource LLC, Novartis Pharmaceuticals Corporation
2/23/18 → 2/28/21
Project: Research project
-
Prot #BAY 1436032/19036: An open-label, non-randomized, multicenter Phase I study to determine the maximum tolerated and/or recommended Phase II dose of oral mutant IDH1 (mIDH1) inhibitor BAY 1436032 and to characterize its safety, tolerability, pharmacok
Covance Inc., Bayer HealthCare Pharmaceuticals, Inc.
2/22/18 → 6/1/19
Project: Research project
-
Prot #H3B-6527-G000-101: An Open-Label Multicenter Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of H3B-6527 in Subjects With Advanced Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma
PPD Investigator Services, LLC, H3 Biomedicine Inc.
2/14/18 → 2/14/21
Project: Research project
-
Characterization of clustered CTCs to eliminate breast cancer metastasis
Liu, H., Cristofanilli, M. & Liu, X.
U.S. Army Medical Research and Materiel Command
1/1/18 → 5/31/21
Project: Research project
-
Survivorship Enhancement in men with prostate cancer At Risk for poor Cognitive Health during treatment with ADT (SEARCH)
Morgans, A. K. & Wang, L.
12/31/17 → 12/31/19
Project: Research project
-
NU 17Z01 (Freenome) - Blood Biomarker Analysis in Patients with Solid Tumors or Lymphoma
12/21/17 → 12/21/20
Project: Research project
-
Prot #STU00206173: c-Met: A Potential Target for the Treatment of Advanced Ovarian Cancer
Matei, D. E., Kocherginsky, M. & Shahabi, S.
12/1/17 → 12/31/21
Project: Research project
-
-
Prot #MO39196: A Phase III, Multicenter, Randomised, Double-Blind, Placebo-Controlled Study of Atezolizumab (Anti-PD-L1 Antibody) in Combination with Paclitaxel Compared with Placebo with Paclitaxel for Patients with Previously Untreated Inoperable Locall
PRA Health Sciences, Genentech, Inc.
11/15/17 → 11/30/21
Project: Research project
-
Prot #BTCRC-GI13-002: An Open Label Randomized Phase I/II Trial of MLN0128 Compared to Sorafenib in Patients with Advanced or Metastatic Hepatocellular Carcinoma: Big Ten Cancer Research Consortium
Hoosier Cancer Research Network, Inc., Millennium Pharmaceuticals, Inc
11/14/17 → 11/14/20
Project: Research project
-
DRUG IMCGP100-202 -A Phase II Randomized, Open-label, Multi-center Study of the Safety and Efficacy of IMCgp100 Compared with Investigator’s Choice in HLA-A*0201 Positive Patients with Previously Untreated Advanced Uveal Melanoma
DrugDev Inc., Immunocore Limited
11/14/17 → 11/14/20
Project: Research project
-
Prot #NC-6004-008: Phase I/II Clinical Trial of NC-6004 in Combination with 5-FU and Cetuximab as First-line Treatment in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of The Head and Neck
Matsangou, M.
PPD Investigator Services, LLC, NanoCarrier Co., Ltd.
10/10/17 → 10/10/20
Project: Research project
-
Prot #DV3-MEL-01: A Phase 1b/2, Open-label, Multicenter, Dose-escalation and Expansion Trial of Intratumoral SD-101 in Combination With Pembrolizumab in Patients With Metastatic Melanoma or Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
PRA Health Sciences, Dynavax Technologies Corporation
10/3/17 → 10/3/20
Project: Research project
-
-
Targeting alpha B-Crystallin in Basal-like Breast Cancer
University of Wisconsin-Madison, Breast Cancer Research Foundation
10/1/17 → 9/30/18
Project: Research project
-
Avon Foundation for Breast Cancer Research and Care Program at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Platanias, L. C., Gius, D. R., Goel, M., Khan, S. A., Clare, S. E., Gius, D. R., Khan, S. A. & Horikoshi, N.
Avon Breast Cancer Crusade LLC
10/1/17 → 12/31/18
Project: Research project
-
PARP inhibition and tumor immunity
Zhang, B., Fang, D. & Sosman, J. A.
9/29/17 → 9/29/19
Project: Research project